BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+7.78%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.01B
AUM Growth
+$7.01B
(+1.7%)
Cap. Flow
-$225M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
36.63%
Holding
168
New
9
Increased
52
Reduced
52
Closed
12
Top Buys
| 1 |
Eli Lilly
LLY
|
$39.6M |
| 2 |
Evolent Health
EVH
|
$38.1M |
| 3 |
Merck
MRK
|
$34.6M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$27.1M |
| 5 |
Humana
HUM
|
$26.3M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$53.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
$51.1M |
| 3 |
HCA Healthcare
HCA
|
$43.5M |
| 4 |
Intuitive Surgical
ISRG
|
$43.3M |
| 5 |
Boston Scientific
BSX
|
$42.1M |
Sector Composition
| 1 | Healthcare | 99.05% |
| 2 | Industrials | 0.87% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Dr. Reddy's Laboratories
RDY
$11.8B
| $5.79M | 0.08% |
458,500
-59,000
| -11% | -$745K |
|
|
NVRO
102
DELISTED
NEVRO CORP.
NVRO
| $5.56M | 0.08% |
218,573
| – | – |
|
|
MTEM
103
DELISTED
Molecular Templates, Inc.
MTEM
| $5.39M | 0.08% |
748,667
| – | – |
|
|
OLK
104
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $4.49M | 0.06% |
239,624
| – | – |
|
|
SGEN
105
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.23M | 0.06% |
22,000
-700
| -3% | -$135K |
|
106
Johnson & Johnson
JNJ
$429B
| $3.51M | 0.05% |
21,225
-1,680
| -7% | -$278K |
|
107
Cencora
COR
$57.2B
| $3.06M | 0.04% |
15,910
| – | – |
|
108
Guardant Health
GH
$8.11B
| $2.94M | 0.04% |
82,197
| – | – |
|
109
Alkermes
ALKS
$4.95B
| $2.56M | 0.04% |
81,700
+17,500
| +27% | +$548K |
|
110
CVS Health
CVS
$93B
| $2.44M | 0.03% |
35,314
+12,500
| +55% | +$864K |
|
111
Sight Sciences
SGHT
$199M
| $2.37M | 0.03% |
286,284
| – | – |
|
|
KRTX
112
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.19M | 0.03% |
10,100
+2,800
| +38% | +$607K |
|
113
Krystal Biotech
KRYS
$4.35B
| $2.11M | 0.03% |
18,000
-300
| -2% | -$35.2K |
|
114
American Well
AMWL
$112M
| $2M | 0.03% |
47,681
-25,428
| -35% | -$1.07M |
|
115
Kosmos Energy
KOS
$803M
| $1.91M | 0.03% |
318,300
| – | – |
|
|
ONC
116
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.82M | 0.03% |
10,200
-48,035
| -82% | -$8.56M |
|
117
Labcorp
LH
$22.8B
| $1.69M | 0.02% |
8,134
| – | – |
|
118
BridgeBio Pharma
BBIO
$9.91B
| $1.67M | 0.02% |
96,900
+14,300
| +17% | +$246K |
|
119
McKesson
MCK
$85.9B
| $1.41M | 0.02% |
3,296
+557
| +20% | +$238K |
|
120
Denali Therapeutics
DNLI
$2.24B
| $1.3M | 0.02% |
44,050
+13,050
| +42% | +$385K |
|
121
Vaxcyte
PCVX
$4.17B
| $1.3M | 0.02% |
+26,000
| New | +$1.3M |
|
|
INBX
122
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.27M | 0.02% |
48,800
+19,100
| +64% | +$496K |
|
123
Akero Therapeutics
AKRO
$3.65B
| $1.27M | 0.02% |
27,100
+1,000
| +4% | +$46.7K |
|
124
89bio
ETNB
$1.37B
| $1.24M | 0.02% |
65,200
-1,800
| -3% | -$34.1K |
|
125
Cytokinetics
CYTK
$5.98B
| $1.21M | 0.02% |
37,100
-17,100
| -32% | -$558K |
|